WAY-262611
Proveedor: ENZO LIFE SCIENCES
DKK1 inhibitor
Wnt pathway agonist acting via inhibition of Dkk1 with no GSK-3β inhibition. TCF-Luciferase EC50=0.63µM. WAY262611 was able to enhance trabecular bone formation rate in the tibia of OVX rats following oral administration.
Formula:
C₂₀H₂₂N₄ |
Número MDL:
MFCD20527803 Núm. CAS: 1123231-07-1 |
|
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...